Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Pirenzepine Hydrochloride

    • Product Name Pirenzepine Hydrochloride
    • Alias Gastrozepin
    • Einecs 246-895-6
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    691650

    Name Pirenzepine Hydrochloride
    Cas Number 29868-97-1
    Molecular Formula C19H21N5O2·HCl
    Molecular Weight 387.87 g/mol
    Appearance White to off-white crystalline powder
    Solubility Soluble in water
    Storage Temperature 2-8°C
    Pharmacological Class Antimuscarinic agent
    Mechanism Of Action Selective M1 muscarinic acetylcholine receptor antagonist
    Therapeutic Use Treatment of peptic ulcers
    Synonyms Gastrozepin, Ro 2-1294
    Route Of Administration Oral
    Pka 7.57
    Melting Point 191-193°C

    As an accredited Pirenzepine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Pirenzepine Hydrochloride is supplied in a sealed amber glass vial containing 1 gram powder, labeled with product details and safety warnings.
    Shipping Pirenzepine Hydrochloride is shipped in tightly sealed, chemically resistant containers to prevent contamination and moisture absorption. It is transported under ambient or controlled room temperature conditions, in compliance with relevant chemical safety regulations. Proper labeling and documentation ensure safe handling. Shipping may be restricted and require appropriate licenses due to its pharmaceutical nature.
    Storage Pirenzepine Hydrochloride should be stored in a tightly sealed container at 2–8°C (refrigerated), protected from light and moisture. Avoid exposure to excessive heat and humidity. Ensure the storage area is well-ventilated and restrict access to authorized personnel. Proper storage conditions ensure the chemical’s stability and efficacy while minimizing safety risks. Always refer to the product's safety data sheet (SDS) for specific instructions.
    Application of Pirenzepine Hydrochloride

    Applications of Pirenzepine Hydrochloride in Industrial Manufacturing

    Pirenzepine Hydrochloride serves specialized pharmaceutical manufacturing needs as an intermediate or active pharmaceutical ingredient (API), with its downstream integration dependent on compliance-critical environments and regulated industrial workflows. The following outlines real downstream application scenarios with details on regulatory frameworks, formulation ratios, process integration, and product outputs for B2B customers in regulated industries.

    1. Antimuscarinic Tablet Formulation Manufacturing

    Pharmaceutical producers use pirenzepine hydrochloride as a key API for antimuscarinic oral solid dosage forms, specifically targeting the treatment of gastrointestinal disorders such as peptic ulcers. Production involves highly controlled GMP zones and rigorous analytical release testing, where the API is carefully compounded with excipients to ensure bioavailability, shelf stability, and correct release kinetics in finished tablet products. The use of this material directly impacts tablet potency consistency and dissolution profiles.

    Industry compliance standards

    • WHO Good Manufacturing Practice (GMP) for pharmaceutical products
    • United States Pharmacopeia (USP) monograph where referenced
    • European Pharmacopoeia (Ph. Eur.) purity and assay specifications
    • ICH Q7 guidelines for active pharmaceutical ingredients

    Typical usage ratio

    • Ranges from 25–150 mg per tablet, depending on the labeled dosage; adjusted based on finished product strength requirements and validated stability studies.

    Downstream process integration

    • The API is blended with direct compression excipients after preliminary micronization, followed by wet or dry granulation, then compressed into tablets, which undergo film coating and blister packaging under GMP control.

    Final product types

    • Prescription antimuscarinic tablets for ulcer management
    • Generic gastrointestinal-modulating oral solid forms

    2. Gastrointestinal Suspension Production

    Leading drug manufacturers employ pirenzepine hydrochloride for liquid suspensions intended for pediatric or geriatric patients requiring adjustable dosing. Achieving uniform dispersion and suspension clarity requires strict quality control over the particle size and solubility profile. The active ingredient enters the compounded mixture post-dissolution via controlled batch mixing using validated, sanitary mixing vessels designed for high-shear blending and homogeneity assurance.

    Industry compliance standards

    • Current Good Manufacturing Practices (cGMP-21 CFR Parts 210/211)
    • European Medicines Agency (EMA) Pediatric Investigation Plan (PIP) compliance where required
    • USP <797> for pharmaceutical compounding—sterile preparations
    • OECD guidelines for non-clinical batch release quality

    Typical usage ratio

    • 0.05–0.2% w/v, tailored per product label strength and viscosity needs, with dose adjustment validated during process development.

    Downstream process integration

    • Active API incorporation follows a multi-step dissolution protocol, followed by high-shear mixing and in-process control sampling prior to aseptic filling and secondary packaging.

    Final product types

    • Oral suspensions for hospital and clinical dispensing
    • Ready-to-use antimuscarinic liquid medications for pediatric/geriatric use

    3. Ophthalmic Solution Preparation

    Ophthalmic pharmaceutical plants utilize pirenzepine hydrochloride in the sterile compounding of investigational or approved eye drop solutions for myopia control or accommodation disorders. The ingredient's entry point lies in the sterile mixing phase, performed inside Class 100 (ISO 5) cleanrooms using validated WFI (Water for Injection) as solvent. Stringent endotoxin control and particulate standards apply from weighing through in-process holding, with filter sterilization conducted immediately prior to unit dose filling.

    Industry compliance standards

    • USP <771> Ophthalmic Products—Quality Tests
    • European Pharmacopoeia 2.9.20 for particulate contamination
    • ISO 13408 for aseptic processing of healthcare products
    • ICH Q3D for elemental impurities evaluation

    Typical usage ratio

    • Typically 0.2–2.0 mg/mL, exactly set per clinical protocol or marketing authorization specifications for ophthalmic solutions.

    Downstream process integration

    • The API dissolves in pre-filtered WFI, followed by sterile filtration (0.22 micron), then aseptic filling into single or multi-dose ophthalmic bottles, capped and labeled in sealed, GMP-compliant packaging operations.

    Final product types

    • Prescription myopia control ophthalmic drops
    • Investigational eye drops for clinical trials

    4. Lyophilized Injectable Drug Manufacturing

    Producers of hospital injectables incorporate pirenzepine hydrochloride in lyophilized (freeze-dried) vials for parenteral administration during clinical research or specified treatment protocols. The compound undergoes preparation in dedicated GMP fill-finish suites, involving precise solution compounding, immediate sterile filtering, and vial dosing prior to controlled freeze-drying cycles. This method enhances the API's long-term stability and preserves sterile integrity from manufacturing through distribution.

    Industry compliance standards

    • FDA 21 CFR Part 210/211 for sterile drug products
    • European Pharmacopoeia (Ph. Eur.) 2.6.1 for sterility
    • ISO 14644 cleanroom classification for aseptic production
    • PIC/S GMP guidance for aseptic processing

    Typical usage ratio

    • 5–50 mg per vial, depending on dosage strengths determined by clinical needs and stability data from pilot-scale lyophilization runs.

    Downstream process integration

    • API is dissolved in a sterile aqueous carrier, filled into vials, semi-stoppered, loaded onto lyophilization shelves, dried under precise vacuum/temperature controls, then stoppered and sealed for distribution.

    Final product types

    • Lyophilized vials for hospital-based injectable reconstitution
    • Clinical trial lots for parenteral antimuscarinic administration
    Free Quote

    Competitive Pirenzepine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Pirenzepine Hydrochloride: A Direct Account from the Manufacturer

    From Our Production Floor to Your Bench: The Story Behind Pirenzepine Hydrochloride

    Disease doesn’t start in a test tube, so the solutions shouldn’t end there. Our approach has always started in the middle of actual work—the spots where quality, reliability, and performance all face off against real-world needs. Pirenzepine Hydrochloride stands as one of those compounds where theory and practice meet head-on. Seeing this material take shape on our production line grants us a perspective that goes beyond what you’ll find in glossy handbooks or generic listings.

    What We Put Into Every Batch

    Every batch starts with high-purity raw materials we vet personally—no shortcuts. There’s a hands-on grit to running reactions for compounds like this. Our senior chemists honed the process so the Pirenzepine Hydrochloride coming out of our reactors has a consistent, high assay and low impurities. The finished product lands in either fine powder or crystalline form, meeting stringent pharmaceutical-grade purity standards. The lot-to-lot uniformity didn’t happen overnight. It took tuning, verification, and a fair amount of troubleshooting to consistently hit a purity threshold above 99%. We check for related substances, residual solvents, and moisture—not because anyone’s watching but because those details show up where it matters most: your outcomes.

    Model and Specifications: Practical Insights

    The chemical formula for Pirenzepine Hydrochloride is C19H21ClN4O2·HCl. It comes as a white to off-white powder, and the melting point falls around 178-183°C. We run spectroscopic analysis—mainly HPLC and NMR—for each lot, because a certificate of analysis means nothing unless we’ve triple-checked the numbers ourselves. That isn’t just about keeping up appearances; contamination or sub-par purity ruins experimental data and wastes valuable researcher time. No one appreciates that after the fact.

    Solubility can sometimes trip up a lab unfamiliar with this compound. Pirenzepine Hydrochloride dissolves well in water, forming a clear solution with gentle stirring. Some other lab-grade products out there cut corners on crystallization, leaving behind undissolved particles that leave researchers scratching their heads. It may seem like a small thing, but those tight specs on appearance and dissolution speed are driven by real user experience—ours included, since we do internal quality control and method validation on every shipment.

    Usage: Bridging Pharmaceutical Theory and Application

    Pirenzepine Hydrochloride comes up most often in gastrointestinal research, particularly when scientists need to antagonize M1 muscarinic acetylcholine receptors. Decades ago, it found its primary clinical role for the treatment of peptic ulcers, helping reduce gastric acid output. These days, a significant share of demand comes from academic and pharmaceutical labs exploring new therapies and mechanisms. We see requests for this compound in studies on neural plasticity and even some work on diabetes-induced neuropathy.

    When we talk to industry colleagues or researchers themselves, the feedback is direct: reliability in response and dose calculations depends on exact mass and chemical identity. That’s why we do not tolerate mislabeling or ambiguity in documentation. Pirenzepine Hydrochloride’s active nature means that even a marginal deviation in concentration can mislead a whole drug discovery program. During pilot studies of new gastric therapies or neurobiology research using Pirenzepine, unclear quality or batch variability can easily throw months of work off course. That’s more than a theoretical risk—it hits reputations and budgets.

    What Sets This Compound Apart

    Pirenzepine Hydrochloride is sometimes overlooked due to the popularity of more aggressive antimuscarinic agents. But raw receptor selectivity often makes a world of difference in targeted applications. Unlike less discriminating agents, Pirenzepine leans more heavily toward M1-selectivity. That’s not just a number on a data sheet. In the hands of scientists looking to probe M1-driven signaling without muddling the effects of M2 or M3 antagonism, this property turns into sharper, more actionable results. Experiments designed to tease apart different muscarinic receptor subtypes rely heavily on such specificity.

    A typical researcher—especially those working on multi-pathway studies—faces enough complexity without adding unknowns in reagent quality. On the manufacturing side, that means pressing every batch through a gauntlet of selective assays. We use LC-MS and IR along with chromatographic purity checks on every kilogram, and our in-process controls shoot for below 0.5% impurities. If we find something out of range, nothing ships. Most pharma supply chains don’t talk about these behind-the-scenes decisions. Yet, as anyone downstream will testify, a consistent baseline lets them compare results year over year, across projects, and with international colleagues.

    Differences from Other Products—From the Ground Up

    We see a lot of interest in the comparison between Pirenzepine Hydrochloride and other antimuscarinic substances—atropine, oxybutynin, or even less familiar agents like telenzepine. Living in the world of synthesis and scale-up, the first clear difference for us comes in the manufacturing complexity. Pirenzepine Hydrochloride requires careful handling during intermediate isolation steps, especially compared to older drugs that tolerate more abrasive processing. This careful approach doesn’t add glamour, but it does minimize side reactions—each of which takes hours or days to track down and trace.

    Researchers often mention fewer off-target effects with Pirenzepine compared to non-selective antagonists. That matches what we’ve heard in clinics in the past. Specificity toward M1 receptors delivers a cleaner pharmacological profile. A chemist might see that difference in kinetic data or binding assays, but a patient or clinician notices fewer unwanted side effects like dry mouth or blurred vision. For scale-up chemists, it’s more practical: tighter specifications on starting materials, more careful reaction temperatures, and more involved purification steps.

    On the storage side, Pirenzepine Hydrochloride stores well at room temperature with simple desiccation—and doesn’t degrade as rapidly as some related compounds that need refrigeration or inert atmosphere. That robust shelf stability, backed by our own accelerated aging studies, translates to real cost savings and management simplicity in the field. No need for fancy transport or unreliable cold chains. It ships safely, and customers receive the same high standard every time.

    Listening to the Market, Responding with Experience

    A lot of what’s written about pharmaceutical compounds these days focuses on theory or downstream outcomes. Our experience, though, comes from handling these materials every day. Take the challenge of upscaling from pilot to commercial scale. While Pirenzepine Hydrochloride’s chemistry is well documented in patents and journals, the real skill lives in scaling without drift: batch size increases must never trade off quality or reproducibility. We’ve spent years refining our crystallization techniques, solvent recycling processes, and filtration setups to ensure continuous supply without loss of purity.

    Feedback from users shapes more of our work than any article or trend. One research group noticed trace byproducts in an otherwise reputable batch from another manufacturer, resulting in a failed toxicity screening. That led us to tighten our impurity spec even further. Now, before we approve any product for release, it has to pass stress tests—moisture, temperature, and light exposure. As a manufacturing team, we take it personally when a batch falls short, because that misstep ripples out into wasted work and lost trust.

    Supporting Advanced Applications

    Academic teams and pharma R&D specialists push Pirenzepine Hydrochloride into new territory every year. Some of the most exciting developments involve neuromodulation experiments in animal models, where precise receptor targeting unlocks insights into learning and memory. Others look at off-label or exploratory uses in gastrointestinal motility or diabetic complications. Not every batch lands in a clinical trial, but every shipment deserves the same attention to genuine detail—no matter its end use.

    Making sure that a shipment of Pirenzepine matches its label right down to the microgram doesn’t require an act of heroism, just discipline. Our QA team cross-checks every batch with reference standards, and those standards are made in-house to rule out inconsistency creeping in from outside suppliers. It takes persistence to maintain that control. In our eyes, the small choices made on the production floor show up later as confidence in research findings or the reliability of preclinical models.

    Hands-On Handling and Practical Advice

    Years of feedback from technicians and bench scientists taught us where the pinch points lie in the real world. Nobody wants to lose product during weighing, so our powder texture avoids excess fines and clumping, making transfer more predictable. Moister probes easily solve for trace water content, but we keep glass vials and desiccant-packed containers on hand for customers who operate in more humid climates. These details aren’t extras. If the product cakes or sticks together before it hits your balances or bioreactors, something went wrong before it left our site.

    We strongly recommend storing Pirenzepine Hydrochloride in a cool, dry place using airtight containers. While degradation isn’t much of an issue compared to some more fragile compounds, long-term exposure to atmospheric moisture can introduce minimal clumping and slightly alter dissolution rates. That may seem like nitpicking to some, but for those looking for the finest reproducibility, it makes a marked difference. Many of the subtle improvements in handling and shelf life came directly from user stories—lost vials, humidity mishaps, or equipment problems prompting us to tweak packaging or synthesis routes.

    Quality: Driven by Direct Accountability

    The only way a manufacturer stays in business for the long haul is by refusing to hide behind paperwork or bureaucratic half-measures. Pirenzepine Hydrochloride is one of those products where we see the same users return year after year—sometimes with specialized needs for analytical method validation, other times to support multi-phase clinical programs. The pressure to deliver unwaveringly pure material doesn’t come from marketing—it comes from the close-knit network of labs depending on us being steadfast and transparent.

    We perform batch release by integrating feedback from customer returns, product recalls across the industry, and near-miss incidents from previous years. Every released lot comes with clear batch records. If there’s ever a discrepancy or a problem, the team that worked on that batch will speak with the customer directly. This direct line between maker and user means any lesson learned gets put right back into process improvements, raw material vetting, or training protocols.

    The Scale-Up Process: What We’ve Learned

    Bringing Pirenzepine Hydrochloride from gram scale to multi-kilogram lots challenged us early on. Small-scale glassware chemistry follows different rules than a vessel that holds 20 liters of reactive solution. Factors like heat transfer, solvent recovery, and crystallization rate all needed fresh solutions at larger volumes. More than a few late nights went into mapping out stirring speeds, seeding protocols, and temperature ramps that give the same reproducible batch quality. Run-to-run reproducibility at scale depends on solid teamwork from process engineers, reaction chemists, and packaging crews all pulling together.

    Environmental and regulatory challenges shape a lot of what we do in fine chemical production. Meeting current good manufacturing practices means dedicating space to proper waste handling, running redundant checks for contamination, and documenting every step. Those details rarely make headlines, but they mean labs and clinics downstream avoid nasty surprises in the form of unexpected contaminants. Consistent scale-up batches give researchers stability year after year, and keep programs from falling behind due to material shortages or unplanned changes in process.

    Working with Customers: The Value of Openness

    Every step in the life of Pirenzepine Hydrochloride, from raw material to finished vial, reflects ongoing dialogue with scientists, formulation specialists, and process technologists. If someone calls in with a problem or question, our chemists talk shop directly—not through layers of customer service. More than a few of our process improvements happened because a user reported a tricky analytical interference or handling issue. We change how we work based on that input.

    The open feedback process lets us adjust specs—say, tightening the allowable range for heavy metals or introducing new particle size analyses—whenever recurring trends point to a real user need. Most importantly, these aren’t just reactions to audits or inspections, but the result of genuine collaboration. Over time, this cycle of making, listening, and tweaking keeps the product right for new science as well as established protocols.

    The Human Element in Manufacturing

    Producing Pirenzepine Hydrochloride doesn’t happen in isolation. Our staff—chemists, engineers, line operators—are the backbone of daily progress. Process knowledge passes from one generation of technicians to the next. Every clever trick to prevent agglomeration in powder, every revision of a filter cake washing sequence, all come from real hands-on problem-solving, usually in response to something that cropped up in a previous batch.

    Origin stories matter—new employees hear about near-failures and critical saves just as much as they learn from SOPs or written checklists. That cultural memory means we never take a record clean run for granted. Most researchers experience the end result of this reliability as a batch that simply dissolves easily and behaves as expected in their experiments. That seamlessness is built on years of attention, sometimes learned the hard way.

    Trust Through Transparency

    Chemical manufacturing isn’t about hype or headline claims—it is about real relationships and real accountability. Pharmaceutical researchers and formulators trust our deliveries of Pirenzepine Hydrochloride because the numbers on the certificate reflect actual, recent, rigorous lab work. If a new impurity turns up in the broader industry, we check against our own runs and inform long-standing customers immediately. Those are the moments where credibility gets built or lost. Confident research needs partners willing to admit mistakes, fix problems quickly, and keep improving.

    Challenges and How We Tackle Them

    We face no shortage of challenges. Global raw material disruptions, shifting regulatory landscapes, the push toward greener manufacturing, and nonstop cost pressures all factor in. For Pirenzepine Hydrochloride, solvent recycling stands out as a key area where we’ve driven improvements. It’s not always glamorous, but cutting down hazardous waste and reusing solvents lowers overhead, benefits the environment, and helps keep supply secure for customers.

    New regulations—especially around genotoxic impurities and residual solvents—force more rigorous testing and force updates to old protocols. These changes sometimes slow us down, but they also sharpen our edge for long-term success. Being a manufacturer means not just keeping pace, but looking ahead, making process investments and documentation adjustments before they become compliance issues.

    Looking Forward

    Every kilogram of Pirenzepine Hydrochloride shipped is the result of sustained effort, feedback from countless users, and years honing a process step by step. While newer agents will keep appearing across research literature, we see continued interest in this compound for its specificity and well-characterized properties. The demands of modern science ask for direct partnerships with makers who consistently deliver quality—and who answer directly to those who use these chemicals in vital research. That’s how we keep refining the process, batch after batch, and why so many of our clients keep working with us year after year.